 |
Top 10 Asthma treatment startups in USA
Oct 11, 2024 | By Jason Kwon | 24 |
1
Funding: $207M
Triveni Bio focuses on the identification of novel disease by combining human genetics and precision medicine.
Triveni Bio focuses on the identification of novel disease by combining human genetics and precision medicine.
2
Funding: $250M
Aiolos Bio is a biotech company developing innovative therapies for respiratory diseases and immune conditions.
Aiolos Bio is a biotech company developing innovative therapies for respiratory diseases and immune conditions.
3
Funding: $160M
Pieris Pharmaceuticals is a clinical-stage biotechnology company that discovers and develops Anticalin-based drugs to target validated disease pathways in a unique and transformative way. Our pipeline includes immuno-oncology multi-specifics tailored for the tumor micro-environment, inhaled Anticalin proteins to treat respiratory diseases, such as uncontrolled asthma, and a half-life-optimized Anticalin protein to treat anemia.
Pieris Pharmaceuticals is a clinical-stage biotechnology company that discovers and develops Anticalin-based drugs to target validated disease pathways in a unique and transformative way. Our pipeline includes immuno-oncology multi-specifics tailored for the tumor micro-environment, inhaled Anticalin proteins to treat respiratory diseases, such as uncontrolled asthma, and a half-life-optimized Anticalin protein to treat anemia.
4
Funding: $85.9M
AnaptysBio is a therapeutic antibody product company and the leader in the use of somatic hypermutation, or SHM, for antibody discovery and optimization. SHM is the body's natural process for generating potent antibodies to fight disease.
AnaptysBio is a therapeutic antibody product company and the leader in the use of somatic hypermutation, or SHM, for antibody discovery and optimization. SHM is the body's natural process for generating potent antibodies to fight disease.
5
Funding: $41M
We create breath-based diagnostic and monitoring devices with the aim to improve the lives of those with respiratory conditions like asthma, COPD, cystic fibrosis and pulmonary hypertension.
We create breath-based diagnostic and monitoring devices with the aim to improve the lives of those with respiratory conditions like asthma, COPD, cystic fibrosis and pulmonary hypertension.
6
Funding: $33.2M
VIDA is a leader in quantitative lung analysis for COPD, emphysema and asthma, establishing objective, reproducible and quantitative
VIDA is a leader in quantitative lung analysis for COPD, emphysema and asthma, establishing objective, reproducible and quantitative
7
Funding: $23.3M
Pneuma Respiratory is focused on creating therapeutic treatments for diseases of the lungs using a digital first platform for inhaled drug delivery. Our focus is to improve the potential effectiveness of currently available and novel drugs, with the initial targets being approved therapeutics for asthma and COPD.
Pneuma Respiratory is focused on creating therapeutic treatments for diseases of the lungs using a digital first platform for inhaled drug delivery. Our focus is to improve the potential effectiveness of currently available and novel drugs, with the initial targets being approved therapeutics for asthma and COPD.
8
Funding: $16.8M
Cohero developed a connected spirometer to assess lung function and medication adherence in asthma and COPD patients. It was designed to be a clinical grade medical device to function as a barometer for lung function. It also produced a patient-facing app that helps users track their data.
Cohero developed a connected spirometer to assess lung function and medication adherence in asthma and COPD patients. It was designed to be a clinical grade medical device to function as a barometer for lung function. It also produced a patient-facing app that helps users track their data.
9
Funding: $3.6M
Sparo Labs is an award-winning startup company in St. Louis dedicated to breathing life into the asthma industry.
Sparo Labs is an award-winning startup company in St. Louis dedicated to breathing life into the asthma industry.
10
Abithas, Inc. is a startup medical device enterprise that seeks to reduce disparity in asthma and copd care and treatment
